Electrical device slows glioblastoma progression
A new study reports that an electrical device worn on the scalp of adults newly diagnosed with glioblastoma can slow the growth of this aggressive brain tumor and extend survival by a few months. The research was recently presented at the Society for Neuro-Oncology meeting.
Image guided radiation therapy improves childhood brain tumor treatments
Image guided radiation therapy, or IGRT, is used throughout a patient’s radiation treatments to help improve the localization of the target. This common practice allows for the radiation to be delivered more precisely and to prevent potential late effects in pediatric brain tumor patients.
Recent discovery could prevent the progression of medulloblastoma
Researchers at the Institut de recherches cliniques de Montréal, or IRCM, have recently discovered that the presence of the Boc protein located on the surface of cells can induce DNA damage in tumor cells. The mutations promote the progression of precancerous lesions into advanced medulloblastoma. The study found that when Boc is inactivated the number of tumors is significantly smaller.
National Institutes of Health award targets new therapies and cell pathways
More than $64 million has been awarded to six research institutions by the National Institutes of Health. The award will create a database of human cellular responses that will aid in the discovery and development of new therapies for many diseases.
Cancer community concerned about EU proposal
A recent European Parliament resolution may impose that researchers be required to ask for a patient's ‘specific’ consent each time new research is carried out on already available data and/or tissues. The unintended consequence of the wording may put at stake the practice of retrospective clinical research, tissue banking and population-based cancer registries.
Childhood cancer survivors face more health issues in adulthood
According to a federally funded study led by researchers at St. Jude Children's Research Hospital, adult survivors of childhood cancer face significant health problems as they age. The study shows that these survivors are five times more likely than their siblings to develop new cancers beyond the age of 35. –Science Daily
Parents donate child’s tumor tissue to research
After losing their 6-year-old son to DIPG, parents Lenore and Trevor Wyant donated his tumor tissue to research, hoping to find answers for other children battling the disease. Because of donated tissue samples, scientists were able to conduct the studies that led to the discovery reported in 2012, that unique genetic mutations are present in 80 percent of DIPG samples. –USA Today